Duke University Hospital (Site 301-006), 2301 Erwin Road

Durham, North Carolina 27710

0 studies enrolling now · 11 studies all time

What they study most

COVID-19, Covid19

Studies at this site

• ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19 — Completed
• Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial) — Completed
• Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial) — Completed
• AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) — Completed
• Vaccination for Recovered Inpatients With COVID-19 (VATICO) — Completed
• PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) — Stopped early
• BRII-196/BRII-198 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) — Completed
• MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) — Completed
• VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) — Completed
• LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) — Completed
• ACTIV-3: Therapeutics for Inpatients With COVID-19 — Completed